Results 111 to 120 of about 4,765 (219)

Pseudohyperphosphatemia in Waldenstrom′s Macroglobulinemia

Indian Journal of Nephrology, 2013
Amalnath, S. D., Dubashi, B.
openaire   +2 more sources

International prognostic scoring system for Waldenstrom macroglobulinemia

, 2009
Recently, many new drugs have been developed for the treatment of Waldenstrom macroglobulinemia (WM). To optimize the treatment according to the prognosis and to facilitate the comparison of trials, we developed an International Prognostic Scoring System
Merlini, Dhodapkar, Madhav V., Meletios A., Duhamel, Alain, Kyle, Robert A., Garcia-Sanz, Ramon, McCoy, Jason, Ocio, Enrique M., Morel, Pierre, Barlogie, Bart, Treon, Steven P., Gobbi, Paolo, Dimopoulos, Giampaolo, Leblond, Veronique, Crowley, John   +15 more
core  

Waldenstrom's macroglobulinemia

, 1999
The clinical manifestations of Waldenstrom’s macroglobulinemia are related to direct tumor infiltration and to the unique properties of the immunoglobulin M monoclonal protein.
Matsouka, C, Galani, E, Dimopoulos, MA
core  

Single-Agent Ibrutinib for Rituximab-Refractory Waldenstrom Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate (TM) Trial

, 2021
Purpose: The first report from the open-label substudy of the phase III iNNOVATE study (PCYC-1127; NCT02165397) demonstrated that single-agent ibrutinib was efficacious and well tolerated in patients with heavily pretreated, rituximab-refractory ...
Matous, Jeffrey V., Trotman, Judith, Ma, Shuo, Briso, Eva M., Tam, Constantine S., Oriol, Albert, Treon, Steven P., Buske, Christian, Tournilhac, Olivier, Tedeschi, Alessandra, MacDonald, David, Arango-Hisijara, Israel, Dimopoulos, Meletios A., Ping, Jerry   +13 more
core  

Walsh & Hoyt: Waldenstrom\u27s Macroglobulinemia

, 2005
This disorder is characterized by a proliferation of B-cells that are morphologically intermediate between plasma cells and lymphocytes and that secrete a monoclonal IgM.
John Kerrison, MD
core  

Irreversible Visual Loss and Optic Nerve Dysfunction Associated with Central Retinal Vein Occlusion in Waldenstrom Macroglobulinemia

, 2007
Irreversible optic nerve dysfunction associated with central retinal vein occlusion (CRVO) is an unusual but important complication of Waldenstrom Macroglobulinemia (WM). Acute visual loss in CRVO is mainly due the severe macular oedema.
ZAINAB BINTI AWANG NGAH
core  

New developments in the management of Waldenström macroglobulinemia

Cancer Management and Research, 2017
Jithma P Abeykoon,1 Uday Yanamandra,2 Prashant Kapoor1,3 1Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA; 2Department of Hematology and Stem Cell Transplant, Army Hospital (Research & Referral), Delhi, India; 3Division of Hematology,
Abeykoon JP, Yanamandra U, Kapoor P
doaj  

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia

Turkish Journal of Hematology, 2023
Nurhilal Büyükkurt, Barış Soydaş
doaj   +1 more source

Refining prognostic tools in Waldenström macroglobulinemia. [PDF]

Blood Adv
Lionel AC, Thomas SK.
europepmc   +1 more source

Waldenstrom's macroglobulinemia

, 2005
The diagnosis of Waldenstrom’s macroglobulinemia (WM) requires evidence of bone-marrow infiltration by lymphoplasmacytoid lymphoma and detection of serum monoclonal protein of IgM type.
Dimopoulos, MA, Anagnostopoulos, A
core